Trademark: 79208982
Word
INFLAZOME TARGETED THERAPIES FOR INFLAMMATORY DISEASES
Status
Registered
Status Code
700
Status Date
Tuesday, October 30, 2018
Serial Number
79208982
Registration Number
5592355
Registration Date
Tuesday, October 30, 2018
Mark Type
3000
Filing Date
Friday, February 3, 2017
Published for Opposition
Tuesday, August 14, 2018

Trademark Owner History
INFLAZOME LIMITED - Original Registrant

Classifications
9 Diagnostic apparatus not for medical purposes; computer software in the field of diagnosis; laboratory apparatus and instruments
5 Diagnostic preparations for medical use; reagents for use in diagnostic tests for medical purposes; medical preparations and articles
1 Chemical reagents for scientific use; chemical diagnostic reagent for industrial use
10 Apparatus and instruments for medical diagnosis
The mark consists of the wording "INFLAZOME TARGETED THERAPIES FOR INFLAMMATORY DISEASES" in stylized green blue lettering, depicted to the right of a hexagon figurative element in orange and green blue.
The hexagon figurative element is in orange and green blue. The verbal elements are in green blue.
The color(s) orange and green blue is/are claimed as a feature of the mark.
"TARGETED THERAPIES FOR INFLAMMATORY DISEASES"

Trademark Events
Oct 30, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 14, 2019
New Representative At Ib Received
Feb 22, 2019
Final Decision Transaction Processed By Ib
Feb 6, 2019
Final Disposition Notice Sent To Ib
Feb 5, 2019
Final Disposition Processed
Jan 30, 2019
Final Disposition Notice Created, To Be Sent To Ib
Oct 30, 2018
Registered-Principal Register
Aug 14, 2018
Official Gazette Publication Confirmation E-Mailed
Aug 14, 2018
Published For Opposition
Aug 11, 2018
Notification Processed By Ib
Jul 25, 2018
Notification Of Possible Opposition Sent To Ib
Jul 25, 2018
Notification Of Notice Of Publication E-Mailed
Jul 25, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 9, 2018
Approved For Pub - Principal Register
Jul 9, 2018
Examiner's Amendment Entered
Jul 9, 2018
Assigned To Lie
Jul 7, 2018
Notification Of Examiners Amendment E-Mailed
Jul 7, 2018
Examiners Amendment E-Mailed
Jul 7, 2018
Examiners Amendment -Written
Jan 13, 2018
Notification Of Priority Action E-Mailed
Jan 13, 2018
Priority Action E-Mailed
Jan 13, 2018
Priority Action Written
Dec 30, 2017
Data Modification Completed
Dec 21, 2017
Teas/Email Correspondence Entered
Dec 21, 2017
Correspondence Received In Law Office
Dec 19, 2017
Assigned To Lie
Dec 12, 2017
Teas Response To Office Action Received
Jul 8, 2017
Refusal Processed By Ib
Jun 18, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jun 17, 2017
Refusal Processed By Mpu
Jun 11, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jun 10, 2017
Non-Final Action Written
Jun 9, 2017
Application Filing Receipt Mailed
Jun 6, 2017
Assigned To Examiner
Jun 5, 2017
New Application Office Supplied Data Entered
Jun 1, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24